Atlas Trials

A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh

Clinical trial NCT04434144 · COMPLETED

Trial details

NCT number
NCT04434144
Sponsor
Upazila Health & Family Planning Officer's (UHFPO) Office, Chakoria, Cox's Bazar
Status
COMPLETED
Study type
OBSERVATIONAL
IvermectinHydroxychloroquineCOVID19
Start date
2020-05-02
Primary completion
2020-06-05
Enrollment
116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.